View Post

Breast cancer drug Kadcyla to remain on NHS after manufacturer lowers price

In In The News by Barbara Jacoby

By: Sarah Boseley From: Drug was set to be dumped from UK’s list of approved medicines before deal was reached with pharmaceutical firm Roche An expensive drug that could prolong the lives of women with advanced breast cancer by at least six months will remain on the list of medicines available on the NHS after the manufacturer agreed to …